1. Home
  2. ANIX vs MGYR Comparison

ANIX vs MGYR Comparison

Compare ANIX & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.89

Market Cap

104.0M

Sector

Health Care

ML Signal

HOLD

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

N/A

Current Price

$17.92

Market Cap

115.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ANIX
MGYR
Founded
1982
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
115.2M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
ANIX
MGYR
Price
$2.89
$17.92
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
81.6K
8.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
2.27%
EPS Growth
12.82
26.83
EPS
N/A
0.50
Revenue
$210,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$35.84
Revenue Growth
N/A
N/A
52 Week Low
$2.33
$13.52
52 Week High
$5.46
$20.00

Technical Indicators

Market Signals
Indicator
ANIX
MGYR
Relative Strength Index (RSI) 46.66 55.05
Support Level $2.74 $17.07
Resistance Level $3.11 $18.96
Average True Range (ATR) 0.16 0.37
MACD 0.00 -0.01
Stochastic Oscillator 40.63 67.48

Price Performance

Historical Comparison
ANIX
MGYR

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

Share on Social Networks: